Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ibopamine--clinical results].

F X Kleber1

  • 1Abteilung für Kardiologie und Pneumologie, Krankenhaus München-Schwabing.

Zeitschrift Fur Kardiologie
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Ibopamine, a dopaminergic stimulant, shows promise in treating chronic heart failure by improving symptoms and potentially prognosis. It offers vasodilatation and enhances renal function without significant beta-receptor side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cement embolism in the vena cava after pedicle screw augmentation].

Der Unfallchirurg·2020
Same author

Resting alveolar gas tensions as a mortality prognosticator in chronic heart failure.

Transplantation proceedings·2010
Same author

[Private medically elite university planned in Berlin (interview by Dr. med. Jochen Aumiller].

MMW Fortschritte der Medizin·2007
Same author

[Structure of the Australian system of 'Diagnosis Related Groups' regarding cardiovascular diseases and corresponding cost weights in Germany].

Zeitschrift fur Kardiologie·2003
Same author

Transcatheter closure of muscular ventricular septal defects in two patients after myocardial infarction.

Journal of interventional cardiology·2002
Same author

Safety and feasibility of a cardiac support device.

Journal of cardiac surgery·2002
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[On pathogenesis of coronary heart disease].

Zeitschrift fur Kardiologie·2016
Same journal

An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Reconstructive surgery of the aortic root].

Zeitschrift fur Kardiologie·2016
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Chronic congestive heart failure therapy has advanced with new vasodilators and inotropic drugs.
  • Dopaminergic stimulation, previously for acute heart failure, is now explored for chronic conditions with ibopamine.

Purpose:

  • To evaluate the therapeutic efficacy and prognostic impact of ibopamine in chronic heart failure management.
  • To assess ibopamine's effects on symptomatology, hemodynamics, and renal function.

Summary:

  • Ibopamine demonstrates vasodilatation, reduces vasoactive hormones, and improves renal blood flow and diuresis.
  • Long-term use shows benefits in edema mobilization, symptom improvement (NYHC), and exercise tolerance.
  • Hemodynamic improvements include increased cardiac output and decreased filling pressures and peripheral resistance.

Related Experiment Videos

Impact:

  • Ibopamine may improve prognosis in chronic heart failure through its multifaceted effects.
  • It enhances diuretic efficacy and serves as a valuable adjunct in pre-cardiac transplantation therapy.
  • The drug provides positive inotropic effects without significant adverse beta-receptor stimulation, like arrhythmias.